Viewing Study NCT00238433


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT00238433
Status: COMPLETED
Last Update Posted: 2017-09-27
First Post: 2005-10-12
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
Sponsor: OHSU Knight Cancer Institute
Organization: